pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,972 catalysts · 4,970 phase readout · 2,318 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×type: phase readout×clear all
type
  • phase readout4,970
  • 8k filing2,318
  • earnings283
  • pdufa277
  • phase 2 completion115
  • phase 1 completion53
phase 1 2 completion
28
  • phase 1 initiation26
  • phase 0 trial completion22
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05464888: Animal Assisted Therapy in Pediatric Dentistry

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07621861: Holy Qur'an Versus Music Sound on Sleep Quality in Children Undergoing Chemotherapy

    Sponsor: Rawand Shafeeq Ali. Phase: NA. Conditions: Sleep Wake Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05216042: GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Cardiovascular Diseases, Natriuretic Peptides, Cardiometabolic Diseases, Energy Expenditure, Glucose Metabolism, Exercise, Obesity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04993742: Effects of Pregnancy-Specific Anxiety on Placental Inflammatory and Oxidative Stress Response and Birth Outcomes

    Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine. Phase: NA. Conditions: Placental Dysfunction, Prenatal Stress

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06054386: Attention Bias Modification Training for Social Phobia (ABMSP)

    Sponsor: University of Wisconsin, Milwaukee. Phase: NA. Conditions: Social Anxiety Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04459273: Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Bladder Carcinoma, Cervical Carcinoma, Cholangiocarcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Hepatocellular Carcinoma, Malignant Adrenal Gland Neoplasm, Malignant Brain Neoplasm, Malignant Pleural Neoplasm, Malignant Skin Neoplasm, Malignant Solid Neoplasm, Malignant Testicular Neoplasm, Malignant Thymus Neoplasm, Neuroendocrine Neoplasm, Thyroid Gland Carcinoma, Urothelial Carcinoma, Cancer of Unknown Primary Site

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT05982873: Expanded Access to Telisotuzumab Adizutecan

    Sponsor: AbbVie. Phase: . Conditions: Solid Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04156373: Fuerte Program for Newcomer Immigrant Youth

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Trauma, Psychological, Mental Disorder in Adolescence, Adolescent - Emotional Problem

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05098769: A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

    Sponsor: Shengjing Hospital. Phase: . Conditions: Pulmonary Embolism and Thrombosis, Deterioration, Clinical

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07242469: A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07355283: IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma

    Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.. Phase: PHASE3. Conditions: Relapsed/Refractory Follicular Lymphoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06919783: Adapting a Health at Every Size Intervention to Obstetric Care

    Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Weight Stigma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07583641: A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults

    Sponsor: argenx. Phase: PHASE2. Conditions: Autoimmune Encephalitis (AE)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06837454: French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

    Sponsor: Sanofi. Phase: . Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04691154: A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

    Sponsor: Liquidia Technologies, Inc.. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension, Pulmonary Hypertension Due to Lung Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04889105: Exercise Therapy for PAD Using Mobile Health

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Peripheral Artery Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07675005: The Prospective, Multicenter, Randomized Controlled Trial of the VentriCure Interventional Left Ventricular Assist System

    Sponsor: Life Shield Medical Technology Co., LTD. Phase: NA. Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07482605: Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

    Sponsor: Jiangmen Central Hospital. Phase: PHASE2. Conditions: Lung Cancer (NSCLC), Malignant Pleural Effusions (Mpe)- Pleurodesis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07460505: Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure

    Sponsor: National University Hospital, Singapore. Phase: NA. Conditions: Heart Failure, OSA - Obstructive Sleep Apnea

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02502266: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fallopian Tube Undifferentiated Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Adenocarcinoma, Ovarian Transitional Cell Carcinoma, Ovarian Undifferentiated Carcinoma, Primary Peritoneal Serous Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04214756: Methodist Acute Pancreatitis Protocol

    Sponsor: Methodist Health System. Phase: . Conditions: Acute Pancreatitis (AP)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04562766: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

    Sponsor: Principia Biopharma, a Sanofi Company. Phase: PHASE3. Conditions: Immune Thrombocytopenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07243756: Gut Microbiome Pill

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07425756: taVNS Combined With TENS on Motor Function in Stroke

    Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07380256: Visual Influences on Vestibular Adaptation

    Sponsor: Emory University. Phase: NA. Conditions: Vestibular Hypofunction, Binocular Vision Abnormalities, Reduced Vision

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03494322: EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer

    Sponsor: University College, London. Phase: PHASE2. Conditions: Head and Neck Cancer, Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06465329: A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07669402: Comparative Evaluation of the Efficacy of Letrozole, L-Carnitine, and Their Combination on Sperm Quality, Oxidative Stress, and ART Outcomes in Men With Idiopathic Oligoasthenoteratozoospermia.

    Sponsor: Tehran University of Medical Sciences. Phase: PHASE2. Conditions: Idiopathic Oligoasthenoteratozoospermia, Male Infertility

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT07354802: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07209202: Fructose Intestinal Gluconeogenesis

    Sponsor: Touro University, California. Phase: NA. Conditions: Healthy Participants, Obese But Otherwise Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04991402: Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir

    Sponsor: Columbia University. Phase: . Conditions: HIV, Obesity, Obesity, Infant, Maternal Obesity During Childbirth, Maternal Obesity Complicating Pregnancy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06473831: MagDI Australia Study

    Sponsor: GT Metabolic Solutions, Inc.. Phase: NA. Conditions: Obesity, Type 2 Diabetes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00496522: Proton Beam Therapy for Chondrosarcoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Chondrosarcoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07049822: Optimising Mammography Screening Accuracy With Blood-based Biomarkers

    Sponsor: Vejle Hospital. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07549022: Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor

    Sponsor: Ankit Mangla, MD. Phase: PHASE1. Conditions: Malignant Peripheral Nerve Sheath Tumors, MPNST

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07370922: Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

    Sponsor: Ain Shams University. Phase: PHASE2. Conditions: Transfusion Dependent Beta Thalassemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07090902: The Effect of Progressive Relaxation Exercise

    Sponsor: Karabuk University. Phase: NA. Conditions: Breastfeeding, Pregnancy, Labor Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03596645: A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

    Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Colitis, Ulcerative

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07611045: CARE Qualitative Study

    Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust. Phase: . Conditions: Cardiac Surgery

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07587580: Fetal Ovarian Cysts and IOTA Terminology for Perinatal Management

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Fetal Ovarian Cyst, Neonatal Ovarian Cyst

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02945579: Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma, Progesterone Receptor Negative, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06920862: Multi-Modal Digital Interventions for Adolescent Weight Management

    Sponsor: National Yang Ming Chiao Tung University. Phase: NA. Conditions: Obesity, Adolescent, Weight Change, Body, Weight Stigma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07485062: Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes

    Sponsor: Western University, Canada. Phase: PHASE4. Conditions: Type 2 Diabetes, Cognitive Decline in Older Adults

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04859946: Itacitinib for the Prevention of Graft Versus Host Disease

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Hematologic and Lymphocytic Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06319027: Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Glioblastoma, IDH-Wildtype

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06556927: The Laughter, Pregnancy, Anxiety and Llife Quality

    Sponsor: Kırklareli University. Phase: NA. Conditions: Anxiety, Life Style, Gestational Diabetes, Pregnancy Related

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04359186: SCOPE Analytic Treatment Interruption Protocol

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: HIV/AIDS

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06089486: MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation

    Sponsor: Ottawa Heart Institute Research Corporation. Phase: NA. Conditions: Cardiac Allograft Vasculopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07574970: A COMBINATION OF RECTAL INDOMETHACIN AND COLD WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS -RCT

    Sponsor: Asian Institute of Gastroenterology, India. Phase: . Conditions: Pancreas Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05681442: Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE4. Conditions: Sepsis

    full page →ctgov ↗
    ← prev
    page 93 of 100
    next →